Efficient induction and isolation of primary CMV-specific CD8+ T-cell responses from CMV seronegative donors for the treatment of serious CMV-related complications in CMV seropositive patients transplanted with a CMV seronegative donor

被引：0
|
作者：
Jedema, I. [1 ]
De Meent, M. Van [1 ]
Van der Heiden, P. L. J. [1 ]
Marijt, W. A. F. [1 ]
Meij, P. [1 ]
Willemze, R. [1 ]
Falkenburg, J. H. F. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] EFFICIENT INDUCTION AND ISOLATION OF A PRIMARY CMV-SPECIFIC CD8+T CELL RESPONSE FROM CMV SERONEGATIVE DONORS FOR THE TREATMENT OF SERIOUS CMV-RELATED COMPLICATIONS IN CMV SEROPOSITIVE PATIENTS TRANSPLANTED WITH A CMV SERONEGATIVE DONOR
    Jedema, I
    van de Meeent, M.
    van der Heiden, P. L. J.
    Marijit, E. W. A.
    Meij, P.
    Willemze, R.
    Falkenburg, J. H. F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 104 - 105
  • [2] Efficient induction and isolation of CMV-specific CD8+ T cells from CMV seronegative donors for the treatment of CMV reactivation in CMV seropositive patients transplanted with a CMV seronegative donor
    Jedema, Inge
    De Meent, Marian Van
    Van der Heiden, Pim L. J.
    Marijt, Erik W. A.
    Meij, Pauline
    Willemze, Roel
    Falkenburg, J. H. Frederik
    BLOOD, 2007, 110 (11) : 319A - 319A
  • [3] In vitro expansion of CMV-specific T cells from CMV seronegative donors.
    Verfuerth, S
    Pizzey, AR
    Chow, SLC
    Chowdhry, N
    Mackinnon, S
    BLOOD, 2005, 106 (11) : 62B - 62B
  • [4] Extending the Option of CMV-Specific T Cells from the CMV-Seronegative Donor
    Hanley, Patrick J.
    Nikiforow, Sarah
    Melenhorst, Jan
    Scheinberg, Phillip
    Savoldo, Barbara
    Dotti, Gianpietro
    Rooney, Cliona M.
    Heslop, Helen E.
    Shpall, Elizabeth J.
    Barrett, A. John
    Bollard, Catherine M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S131 - S131
  • [5] CMV-Seropositive patients allografted with a CMV-seronegative donor show delayed or missing CMV-specific T-Cell immune response and are at higher risk for CMV-viremia and CMV-disease.
    Ganepola, S
    Gentilini, C
    Hilbers, U
    Hartung, G
    Lange, T
    Hofmann, J
    Liebert, UG
    Hammer, M
    Engelmann, E
    Niederwieser, D
    Thiel, E
    Uharek, L
    BLOOD, 2005, 106 (11) : 908A - 908A
  • [6] CMV-Specific CD4+ T Cells in CMV-IgG-Seronegative Individuals Protect from CMV Viremia Following Transplantation with a CMV-Seropositive Donor Kidney
    Litjens, N.
    Huang, L.
    Dedeoglu, B.
    Meijers, R.
    Betjes, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 520 - 521
  • [7] Grafting T-cells of CMV-seronegative donors with CMV-specific T-cell receptor RNA
    Thomas, S.
    Klobuch, S.
    Heemskerk, M.
    Stolle, D.
    Besold, K.
    Plachter, B.
    Voss, H.
    Theobald, M.
    Herr, W.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S65 - S66
  • [8] CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
    Schachtner, Thomas
    Stein, Maik
    Reinke, Petra
    TRANSPLANTATION, 2017, 101 (10) : E315 - E325
  • [9] CMV-specific donor T cells for the treatment of recurrent CMV infections in transplanted patients
    Tonn, T.
    Grigoleit, G. U.
    Busch, D.
    Germeroth, L.
    Schuly, N.
    Anderl, F.
    Odendahl, M.
    Seifried, E.
    Einsele, H.
    VOX SANGUINIS, 2008, 95 : 203 - 203
  • [10] Variations in cytomegalovirus (CMV) antigen-specific T-cell frequency in CMV seropositive and seronegative stem cell donors.
    Hensel, N
    Clave, E
    Bradstock, K
    Barrett, J
    Barret, A
    BLOOD, 1999, 94 (10) : 340A - 340A
12345